[
  {
    "ts": null,
    "headline": "Tracking Tweedy Browne Portfolio - Q2 2025 Update",
    "summary": "Tweedy Browneâs Q2 2025 portfolio reveals disciplined value investing with key holdings in CNH, Berkshire Hathaway, and Alphabet. See more here.",
    "url": "https://finnhub.io/api/news?id=e03c713ba631d609f2c49ccff7a742056cefa93b4a09a750ba29c0e3b62a041b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755124466,
      "headline": "Tracking Tweedy Browne Portfolio - Q2 2025 Update",
      "id": 136342725,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/953164652/image_953164652.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Tweedy Browneâs Q2 2025 portfolio reveals disciplined value investing with key holdings in CNH, Berkshire Hathaway, and Alphabet. See more here.",
      "url": "https://finnhub.io/api/news?id=e03c713ba631d609f2c49ccff7a742056cefa93b4a09a750ba29c0e3b62a041b"
    }
  },
  {
    "ts": null,
    "headline": "Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks?",
    "summary": "Eli Lilly, CorMedix and Johnson & Johnson represent a diversified mix of healthcare stocks with bullish catalysts",
    "url": "https://finnhub.io/api/news?id=6ae8ed4f7793c02a01e9869027bef19731999ab40c7f641e9014273649cf89e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755101820,
      "headline": "Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks?",
      "id": 136339411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Eli Lilly, CorMedix and Johnson & Johnson represent a diversified mix of healthcare stocks with bullish catalysts",
      "url": "https://finnhub.io/api/news?id=6ae8ed4f7793c02a01e9869027bef19731999ab40c7f641e9014273649cf89e0"
    }
  },
  {
    "ts": null,
    "headline": "Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi",
    "summary": "The Saudi Arabia Clinical Chemistry Analyzer Market is set to reach US$ 249.11 million by 2033, growing from US$ 170.98 million in 2024 at a 4.27% CAGR. Market growth is fueled by government healthcare investments under Vision 2030, alongside rising chronic diseases and an aging population demanding precise diagnostics. Technological advancements in automation, AI integration, and point-of-care testing further enhance accessibility, especially in underserved areas. With increasing involvement fr",
    "url": "https://finnhub.io/api/news?id=16acc0a5636a83fdea177fe0b8c82b7fce275e73343404759f50859aad796588",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755094260,
      "headline": "Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi",
      "id": 136339446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The Saudi Arabia Clinical Chemistry Analyzer Market is set to reach US$ 249.11 million by 2033, growing from US$ 170.98 million in 2024 at a 4.27% CAGR. Market growth is fueled by government healthcare investments under Vision 2030, alongside rising chronic diseases and an aging population demanding precise diagnostics. Technological advancements in automation, AI integration, and point-of-care testing further enhance accessibility, especially in underserved areas. With increasing involvement fr",
      "url": "https://finnhub.io/api/news?id=16acc0a5636a83fdea177fe0b8c82b7fce275e73343404759f50859aad796588"
    }
  },
  {
    "ts": null,
    "headline": "3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income",
    "summary": "The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",
    "url": "https://finnhub.io/api/news?id=cf3696b10fead252bc17f6b01635fa34b05f0ad01a182878def9ce9935768ee4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755090603,
      "headline": "3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income",
      "id": 136339447,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",
      "url": "https://finnhub.io/api/news?id=cf3696b10fead252bc17f6b01635fa34b05f0ad01a182878def9ce9935768ee4"
    }
  },
  {
    "ts": null,
    "headline": "Shan Jegatheeswaran shares J&J’s vision for AI in the OR",
    "summary": "By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in procedures.",
    "url": "https://finnhub.io/api/news?id=5b2d595a1f3d9e6f8285a4105679238b485b18c8fe6642651a8c8e7da43b75b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755089582,
      "headline": "Shan Jegatheeswaran shares J&J’s vision for AI in the OR",
      "id": 136339448,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in procedures.",
      "url": "https://finnhub.io/api/news?id=5b2d595a1f3d9e6f8285a4105679238b485b18c8fe6642651a8c8e7da43b75b4"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys",
    "summary": "See here for more on July's investment insights: record-breaking dividends, high-yield BDCs, and strategies for steady income growth.",
    "url": "https://finnhub.io/api/news?id=642c79a5d7ace207c9d722f9b6e969419b05a47cf1edf5c3505e32f7b283a55b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755072900,
      "headline": "My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys",
      "id": 136327951,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "See here for more on July's investment insights: record-breaking dividends, high-yield BDCs, and strategies for steady income growth.",
      "url": "https://finnhub.io/api/news?id=642c79a5d7ace207c9d722f9b6e969419b05a47cf1edf5c3505e32f7b283a55b"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Canine Orthopedics Market size & share revenue was valued at approximately USD 420.2 Million in 2024 and is expected to reach USD 454.6 Million in 2025 and is expected to reach around USD 945.2 Million by 2034, at a CAGR of 8.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are B. Braun Melsungen AG, Movo",
    "url": "https://finnhub.io/api/news?id=472881e308433ac1b91e9ea145a32c818f74d99a0aabc6b98d5551a27e1b53ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755059400,
      "headline": "[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136327041,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Canine Orthopedics Market size & share revenue was valued at approximately USD 420.2 Million in 2024 and is expected to reach USD 454.6 Million in 2025 and is expected to reach around USD 945.2 Million by 2034, at a CAGR of 8.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are B. Braun Melsungen AG, Movo",
      "url": "https://finnhub.io/api/news?id=472881e308433ac1b91e9ea145a32c818f74d99a0aabc6b98d5551a27e1b53ae"
    }
  }
]